Case Report Status Epilepticus in a 45-Year-Old Male with Dyke-Davidoff-Masson Syndrome

A 45-year-old male presented with status epilepticus and was subsequently diagnosed with Dyke-Davidoff-Masson Syndrome (DDMS), a rare neurological disorder characterized by cerebral hemiatrophy, seizures, hemiplegia, and cranial asymmetry. This case highlights the clinical features, imaging findings, and management of DDMS in adulthood, contributing to the limited literature on late presentations of this syndrome. The patient's acute condition was managed with antiepileptic therapy, and follow-up strategies were established to address chronic neurological deficits. This report underscores the need for heightened awareness of DDMS in adult seizure presentations and provides insights into its long- term management.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-27
DOI
https://doi.org/10.5281/zenodo.14928743
Primary Topic
Sphingolipid Metabolism and Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report Status Epilepticus in a 45-Year-Old Male with Dyke-Davidoff-Masson Syndrome

Zenodo (CERN European Organization for Nuclear Research)
Sphingolipid Metabolism and Signaling
article

Case Report Status Epilepticus in a 45-Year-Old Male with Dyke-Davidoff-Masson Syndrome

article en

Abstract

A 45-year-old male presented with status epilepticus and was subsequently diagnosed with Dyke-Davidoff-Masson Syndrome (DDMS), a rare neurological disorder characterized by cerebral hemiatrophy, seizures, hemiplegia, and cranial asymmetry. This case highlights the clinical features, imaging findings, and management of DDMS in adulthood, contributing to the limited literature on late presentations of this syndrome. The patient's acute condition was managed with antiepileptic therapy, and follow-up strategies were established to address chronic neurological deficits. This report underscores the need for heightened awareness of DDMS in adult seizure presentations and provides insights into its long- term management.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 62%
Sphingolipid Metabolism and Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.